Skip to content
Top Menu
  • Subscribe Newsletter
  • 中文
GeneOnline News

GeneOnline News

The Next Generation Biotech Media

MENUMENU
  • Home
  • COVID-19
  • Topics
        • Asia Insight
        • Latest News
        • North America
        • International
  • Technology
  • Feature
  • Industry News
  • BIO Asia-Taiwan
  • Interview
  • Event
  • linkedin

Tag: cancer

North America

FDA Greenlights Pfizer’s Xalkori for a Rare Form of Non-Hodgkin Lymphoma

2021-01-182021-01-18 - by GeneOnline Team - Leave a Comment

On January 15th, Pfizer announced FDA approval for its tyrosine kinase inhibitor, Xalkori, which can be used in pediatric patients one year of age and older and young adults with …

Read More
Asia Insight / Deals

Takeda, KSQ Join Forces to Identify NK Cell Targets For Cancer Therapies

2021-01-15 - by GeneOnline - Leave a Comment

Cancer therapy without a doubt will be one of the most trending topics in 2021. As several contenders push their way into the field, on January 13, Japanese biopharma, Takeda …

Read More
Asia Insight / Deals

Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration

2021-01-142021-01-15 - by GeneOnline - Leave a Comment

In recent times, several big pharma have collaborated with small companies in the immuno-oncology field. Last September, Pfizer made a $200 million investment to collaborate with CStone Pharmaceuticals. Now Novartis …

Read More
Asia Insight

Daiichi Sankyo Files NDA for a New Oncolytic Virus in Japan

2021-01-07 - by GeneOnline - Leave a Comment

On January 5th, Daiichi Sankyo announced the submission of a New Drug Application (NDA) to Japan’s Ministry of Health, Labour and Welfare (MHLW) for teserpaturev (G47∆), an oncolytic virus, for …

Read More
Investment / North America

Investors Bet $120 Million on Ikena Oncology’s Cancer Therapies

2021-01-06 - by GeneOnline - Leave a Comment

The new year has brought good news for Boston-based Ikena oncology, which raised $120 million to push its pipeline of patient-specific, next-generation targeted oncology and immunometabolism therapies. This funding comes …

Read More
Asia Insight / Clinical Trials

Lynparza Bags Multiple Approvals in Japan

2021-01-042021-01-05 - by GeneOnline - Leave a Comment

On December 28th, Merck and AstraZeneca announced that their PARP inhibitor Lynparza received approval from Japan to treat ovarian, prostate, and pancreatic cancers. The approvals by the Japanese Ministry of Health, …

Read More
Feature

Chromosome Breakage Helps Cancer Cells Develop Drug Resistance

2020-12-28 - by GeneOnline - Leave a Comment

Cancer is a particularly challenging problem to solve since it can learn to override and resist treatment. Multiple mechanisms can help cancer evade therapy and develop resistance. In a new …

Read More
International

Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment

2020-12-252020-12-25 - by GeneOnline - Leave a Comment

On December 23rd, Roche announced that it had received approval for the usage of Phesgo, a therapy containing two monoclonal antibodies against the human epidermal growth factor receptor 2 (HER2) …

Read More
Asia Insight

Bayer’s New Anti-Tumor Drug BAY 2416964 Receives Approval for Clinical Use in China

2020-12-232020-12-23 - by GeneOnline - Leave a Comment

The Center for Drug Evaluation (CDE) accepted Bayer’s clinical application for BAY 2416964 tablets submitted in category 1 of chemical drugs on October 16th. On December 17th, it has given …

Read More
Industry News / M&A

Servier Aims to Expand Portfolio for Hematological Cancers by Acquiring Agios

2020-12-22 - by GeneOnline - Leave a Comment

On December 21st, Servier announced that it would acquire Agios Pharmaceuticals for up to $2 billion. This acquisition will give Servier two FDA approved therapeutics, TIBSOVO, and IDHIFA, as well …

Read More

Posts navigation

1 2 … 14 Next

TODAY IN HISTORY

June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
Today In History
June 28, 2004: NHGRI Established Centers of Exellence in Genomic Science at Havard and Johns Hopkins University
2018-06-29
Tweets by GeneOnlineNews
  • Home
  • Feature
  • Technology
  • Industry News
  • Event
  • Topics
    • COVID-19
    • Asia Insight
    • International
    • Latest News
    • North America

MEDIA INQUIRIES

service@geneolineasia.com

website

Chinese
Copyright © 2021 GeneOnline News.
Powered by WordPress and HitMag.

[pie_register_login]